AFT Pharmaceuticals today announced that Dr Doug Wilson will step down from its Board of Directors at the conclusion of the company’s Annual Meeting of Shareholders on 5 August 2022.
Dr Wilson joined the AFT Board in 2012 following a distinguished career in academia and business and with deep experience spanning pharmaceutical research, development and commercialisation.
AFT Pharmaceuticals Chair David Flacks and Managing Director Dr Hartley Atkinson praised Dr Wilson's invaluable contribution to the company.
See more
